Bullboard - Stock Discussion Forum Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to... see more

Add To Watchlist

TSXV:SBM - Post Discussion

Sirona Biochem Corp > Licensing agreement uncertainty

View:

Post by lscfa on Oct 04, 2022 6:53pm

Licensing agreement uncertainty

Abbvie is not obligated to commercial the 1067 tech. Abbvie is not obligated to proceed in a timely manner. Sirona has no recourse if Abbvie does not act. Recall how long Wanbang took and eventually terminate?

209

Comment

Comment by lscfa on Oct 04, 2022 7:07pm

Sirona has not uttered a word about the non-exclusive deal with R+F. Is it still in effect now that Abbvie has a global exclusive deal?

106

Comment

Comment by navajojoe on Oct 04, 2022 7:32pm

This post has been removed in accordance with Community Policy

Comment by hcdtrading on Oct 04, 2022 7:48pm

This post has been removed in accordance with Community Policy

Comment by MirrorWorldMan on Oct 04, 2022 8:46pm

This post has been removed in accordance with Community Policy

Comment by forhandlaren on Oct 04, 2022 11:42pm

To be fair, we don't know the full extent of the deal. It could include a condition saying that Abbvie must lauch a product within a timeframe or they loose the rights.

Comment

Comment by navajojoe on Oct 05, 2022 9:34am

This post has been removed in accordance with Community Policy

Comment by lscfa on Oct 06, 2022 2:47pm

Reply from IR: From: Michelle Seltenrich Date: October 6, 2022 at 12:10:20 PM MDT To: Xxxxxxxxxx Subject: RE: Non-disclosure is Sirona's choice Abbvie is not obligated to commercial the 1067 tech. Abbvie is not obligated to proceed in a timely manner. Sirona has no recourse if Abbvie does not act. Recall ...more

219

Comment

Comment by SironaInvestor on Oct 06, 2022 3:21pm

Yes, probably further 500k penalty fee when they not bring it to market. This game is not over, but the doctor has simply missinterpreted the situation. Some great new fancy presentation with smily faces on will not help the share price. The first milestone payment will maybe visible in a half year but this is also very optimistic having the timelines in mind from R&F. So the only thing which ...more

174

Comment

Comment by MirrorWorldMan on Oct 06, 2022 10:56pm

Thats not good enough of a response. How much is the penalty? What is the permitted maximum time frame for launch? What are the milestone markers, the royalty percentage. What is it with this company and presenting real dates and numbers? Again, Howie wants investors to give real dollars to Sirona but will not give any real numbers on in return. Words and hype, stupid smiles and ...more

167

Comment

Sirona Biochem Corp